What is the recommended treatment for acute bacterial sinusitis in an adult?

Treatment of Acute Bacterial Sinusitis in Adults

For adults with acute bacterial sinusitis, either offer watchful waiting for up to 7 days with assured follow-up, or prescribe amoxicillin with or without clavulanate as first-line antibiotic therapy for 5-10 days. 1, 2, 3, 4

Initial Management Decision: Antibiotics vs. Watchful Waiting

The most recent 2025 AAO-HNS guideline emphasizes that watchful waiting without antibiotics is a recommended initial approach for uncomplicated acute bacterial rhinosinusitis (ABRS) 3, 4. This strategy is supported by high-quality evidence showing that most patients improve spontaneously—only 10-15 more people per 100 will benefit from antibiotics compared to placebo 2, 5.

When to Choose Watchful Waiting:

• Mild to moderate symptoms (facial pain/pressure, purulent nasal discharge, nasal congestion)
• Temperature <38.3°C (101°F)
• Assured follow-up within 7 days
• No severe illness indicators
• Patient can start antibiotics if symptoms worsen or fail to improve by day 7 2

When to Start Immediate Antibiotics:

• Severe symptoms: High fever ≥39°C (102°F), severe facial pain, or purulent discharge for ≥3-4 consecutive days 1, 6
• Immunocompromised state, diabetes, or significant comorbidities 1
• Age >65 years 1
• Frontal or sphenoidal sinusitis 1
• History of recurrent ABRS 1
• Patient preference after shared decision-making 2

Antibiotic Selection

First-Line Therapy:

Amoxicillin (with or without clavulanate) is the recommended first-line antibiotic 1, 2. The choice between plain amoxicillin versus amoxicillin-clavulanate depends on risk factors for resistant organisms 1.

Use Plain Amoxicillin (500 mg twice daily) for:

• Most adults without risk factors for resistance
• Cost-effective, narrow-spectrum, safe 1, 2

Use Amoxicillin-Clavulanate (875/125 mg twice daily OR high-dose 2000/125 mg twice daily) when:

• Antibiotic use in past month 1
• Moderate to severe symptoms 1
• Recent hospitalization 1
• Close contact with daycare children 1
• Healthcare worker or frequent healthcare exposure 1
• Smoker or household smoker 1
• High local prevalence of resistant bacteria 1
• Age >65 years 1
• Diabetes or chronic cardiac/hepatic/renal disease 1
• Immunocompromised 1

High-dose amoxicillin-clavulanate (2000 mg amoxicillin/125 mg clavulanate twice daily or 90 mg/kg/day divided twice daily, max 2g q12h) is specifically recommended for coverage of penicillin-nonsusceptible Streptococcus pneumoniae 7, 1.

For Penicillin-Allergic Patients:

Doxycycline OR respiratory fluoroquinolone (levofloxacin 500 mg daily or moxifloxacin 400 mg daily) 1, 6

• Doxycycline: 100 mg twice daily 6
• Levofloxacin: 500 mg once daily 1, 7
• Moxifloxacin: 400 mg once daily 1, 7

Important caveat: Macrolides (azithromycin, clarithromycin) are NOT recommended as first-line due to high resistance rates among S. pneumoniae and H. influenzae 7.

Duration of Therapy

5-7 days of antibiotics may be equally effective as 10 days, with fewer side effects 1, 2. The traditional 10-14 day course remains acceptable, but shorter courses should be discussed with patients to reduce adverse events 7, 2.

Reassessment for Treatment Failure

If symptoms fail to improve after 7 days or worsen at any time, reassess the patient 1, 2:

1. Confirm ABRS diagnosis (exclude viral rhinosinusitis, allergic rhinitis, other diagnoses)
2. Evaluate for complications (orbital involvement, intracranial extension, severe headache, proptosis, cranial nerve deficits) 1
3. Switch antibiotics if already on treatment:
   • If started on amoxicillin → switch to amoxicillin-clavulanate or respiratory fluoroquinolone 7, 1
   • If started on amoxicillin-clavulanate → switch to respiratory fluoroquinolone 7, 1
   • Consider broader coverage: cefuroxime, cefpodoxime, cefdinir 7

Adjunctive Symptomatic Therapy

Offer symptomatic relief regardless of antibiotic decision 2, 4:

• Analgesics: Acetaminophen or ibuprofen for pain/fever 2
• Intranasal saline irrigation: Reduces symptoms, helps mucus clearance 6, 2
• Intranasal corticosteroid sprays: Modest benefit after 15 days of use (NNT=14), may reduce need for antibiotics 7, 6, 2
• Decongestants: Oral or topical (limit topical use to ≤3 days to avoid rebound congestion) 2

Avoid routinely: Antihistamines (unless atopic patient) and oral corticosteroids—no proven benefit and potential side effects 2.

Critical Pitfalls to Avoid

1. Do NOT obtain imaging (CT/X-ray) for uncomplicated ABRS—diagnosis is clinical 1, 3. Imaging only indicated if complications or alternative diagnosis suspected 1, 3.

2. Do NOT prescribe antibiotics for viral rhinosinusitis (symptoms <10 days without worsening) 6, 2, 3—this is the most common cause of inappropriate antibiotic use 6.

3. Do NOT use macrolides or first-generation cephalosporins as first-line therapy—inadequate coverage of resistant organisms 7.

4. Recognize "double worsening"—initial improvement followed by worsening within 10 days strongly suggests bacterial superinfection 1, 2, 3.

5. Severe diarrhea occurs more frequently with high-dose amoxicillin-clavulanate (15.8% vs 4.8% with standard dose) 8—counsel patients accordingly.

Evidence Quality Note

There is notable divergence between guidelines: the 2012 IDSA guideline 6 recommends immediate antibiotics (amoxicillin-clavulanate preferred) once ABRS is diagnosed, while the AAO-HNS guidelines 1, 2, 3, 4 emphasize watchful waiting as initial management. The most recent 2025 AAO-HNS guideline represents the current standard, prioritizing watchful waiting to reduce antibiotic overuse and resistance 3, 4. The absolute benefit of antibiotics is modest—only 5-11 more people per 100 are cured faster with antibiotics 2, 5—while 13 more per 100 experience adverse effects 5.